NCT01229839View on ClinicalTrials.gov

Chemoembolization With or Without Mixing the Chemotherapy With Lipiodol for Unresectable HCC

PHASE3CompletedINTERVENTIONAL
Enrollment

668

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

August 31, 2018

Study Completion Date

August 31, 2018

Conditions
Hepatocellular Carcinoma
Interventions
OTHER

Embolization

embolization with lipiodol and polyvinyl alcohol particles (PVA)

OTHER

Infusion of anticancer agent

infusion with chemotherapy drugs (EADM 50mg, lobaplatin 50mg, and MMC 6mg ) desolved in water

OTHER

Infusion of mixture of anticancer agent and lipiodol

infusion of mixture of lipiodol and chemotherapy drugs (EADM 50mg, lobaplatin 50mg, and MMC 6mg)dissolved in water-soluble contrast medium and distilled water

Trial Locations (1)

Unknown

Cancer Center Sun Yat-sen University, Guangzhou

All Listed Sponsors
lead

Sun Yat-sen University

OTHER

NCT01229839 - Chemoembolization With or Without Mixing the Chemotherapy With Lipiodol for Unresectable HCC | Biotech Hunter | Biotech Hunter